- Generic name
- Elagolix
- Strength
- 200 mg
- Dosage form
- Tablet
- Manufactured by
- Square Pharmaceuticals PLC.
Orili 200 Tablet
About Orili 200 Tablet
Orili 200 is a 200 mg tablet containing elagolix, a gonadotropin-releasing hormone antagonist used to manage moderate to severe pain linked with endometriosis. It is a prescription medicine, and a doctor decides whether it is suitable.
There are 8 brands of Elagolix listed in Bangladesh. The lowest listed price is Elagox 150 mg Tablet at ৳ 170.00 per unit.
What is Orili 200 Tablet?
Orili 200 is a tablet made by Square Pharmaceuticals PLC. It contains elagolix 200 mg and belongs to a group of medicines called gonadotropin-releasing hormone antagonists. It is used for the management of moderate to severe pain associated with endometriosis, a condition in which tissue similar to the lining of the uterus grows outside it. The medicine is taken by mouth. Because treatment needs careful assessment, the doctor decides the dose, the course and how long it should be continued. Do not start, change or stop it without medical advice.
Uses of Orili 200
Orili 200 is used to manage moderate to severe pain linked with endometriosis. In endometriosis, tissue similar to the uterine lining grows outside the uterus, and this can cause pain during periods, pelvic pain between periods and pain during sex. The medicine works by blocking a hormone signal that supports the growth of these lesions. It is intended for use under a doctor's care, and the doctor will decide whether it is appropriate for your situation.
How to use Orili 200
Orili 200 is a tablet that is swallowed. The doctor decides the dose, how often it is taken and how long the course lasts. It may be taken with or without food. The doctor will also check that you are not pregnant before treatment begins and will explain any tests needed. Follow the instructions given to you, and ask your doctor or pharmacist if anything is unclear. Do not change the dose or stop the medicine on your own.
Side effects of Orili 200
Common side effects reported with elagolix include hot flushes and night sweats, headache, nausea, insomnia, missed periods, anxiety, joint pain and mood changes or depression-related symptoms. Some people may have other reactions. Tell your doctor if you notice mood changes, depression, or thoughts of self-harm, or if side effects bother you. Your doctor can advise on what to do. Seek medical attention promptly for any serious or unexpected symptoms.
Safety and precautions
Orili 200 is contraindicated in pregnancy, and pregnancy should be excluded before starting treatment. It may reduce the ability to recognise pregnancy, so testing is done if pregnancy is suspected, and the medicine is stopped if pregnancy is confirmed. It is not for women with known osteoporosis or severe liver impairment. It may lower bone mineral density, so the doctor may assess bone health. Tell your doctor about depression, mood problems, liver disease or other medicines you take, including hormonal contraceptives. Ask your doctor before use if you are breastfeeding.
Frequently asked questions
Is Orili 200 safe during pregnancy or breastfeeding?
It is not to be used during pregnancy, as exposure early in pregnancy may increase the risk of pregnancy loss. Pregnancy should be excluded before treatment. There is no information on its presence in human milk, so ask your doctor before breastfeeding.
What is Orili 200 used for, and what kind of medicine is it?
Orili 200 is used to manage moderate to severe pain associated with endometriosis. It contains elagolix, which is a gonadotropin-releasing hormone antagonist. It is a prescription medicine, and the doctor decides whether it is suitable for you.
What do the tablet form and 200 mg strength mean?
The tablet is the oral dosage form, meaning it is swallowed. The 200 mg strength tells you how much elagolix each tablet contains. The doctor decides the dose and course; do not change it yourself.
What should I tell my doctor before starting Orili 200?
Tell your doctor about pregnancy or plans to become pregnant, breastfeeding, known osteoporosis, liver problems, depression or mood disorders, and all other medicines you take, including hormonal contraceptives. The doctor will decide if the medicine is appropriate.
Indications
Pharmacology
Elagolix is an orally-administered, nonpeptide small molecule gonadotropin-releasing hormone (GnRH) receptor antagonist that inhibits endogenous GnRH signaling by binding competitively to GnRH receptors in the pituitary gland Label. Administration of elagolix results in dose-dependent suppression of luteinizing hormone (LH) and follicle-stimulating hormone (FSH), leading to decreased blood concentrations of the ovarian sex hormones, estradiol and progesterone.
Dosage & Administration
Initiate treatment with Elagolix 150 mg once daily-
- Maximum Treatment Duration: 24 months
- Coexisting Condition: None
- Maximum Treatment Duration: 6 months
- Coexisting Condition: Dyspareunia
- Maximum Treatment Duration: 6 months
- Coexisting Condition: Moderate hepatic impairment (Child-Pugh Class B)
Interaction
Contraindications
- Who are pregnant
- Exposure to ORILISSA early in pregnancy may increase the risk of early pregnancy loss.
- With known osteoporosis because of the risk of further bone loss
- With severe hepatic impairment because of the risk of bone loss
- With concomitant use of strong organic anion transporting polypeptide (OATP) 1B1 inhibitors (e.g., cyclosporine and gemfibrozil)
Side Effects
Pregnancy & Lactation
There are no adequate animal data on the excretion of Elagolix in milk. The developmental and health benefits of breastfeeding should be considered along with the mother’s clinical need for Elagolix and any potential adverse effects on the breastfed child from Elagolix.
Precautions & Warnings
- Bone Loss: Dose- and duration-dependent decreases in bone mineral density (BMD) that may not be completely reversible. Assess BMD in women with additional risk factors for bone loss
- Reduced Ability to Recognize Pregnancy: Elagolix may alter menstrual bleeding, which may reduce the ability to recognize pregnancy. Perform testing if pregnancy is suspected. Discontinue if pregnancy is confirmed
- Suicidal Ideation and Mood Disorders: Advise patients to seek medical attention for suicidal ideation, suicidal behavior, new onset or worsening depression, anxiety, or other mood changes
- Hepatic Transaminase Elevations: Dose-dependent elevations in serum alanine aminotransferase (ALT). Counsel patients on signs and symptoms of liver injury
- Potential for Reduced Efficacy with Estrogen-Containing Contraceptives: Use non-hormonal contraception during treatment and for one week after discontinuing Elagolix.
Overdose Effects
Storage Conditions
Alternative brands of Elagolix
Other brands with the same generic name, cheapest first.
Medicine information is for reference only and is not medical advice. Always follow your doctor's prescription and check with a pharmacist.